Updated Date: Thu, 12 Mar 2026 00:00:00 EDT
Early trial shows more than 50% LRRK2 reduction and supports expansion into other neurodegenerative conditions
Lead Alzheimer’s candidate shows clear biological effects and antidepressant potential
Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by […]
Hospices in England are facing a growing financial crisis and will be forced to cut vital palliative and […]
More than 400 people have been killed in an airstrike on a hospital in Afghanistan’s capital Kabul, which […]
Gastro-oesophageal adenocarcinoma (GOAC) is a global challenge, ranking among the leading causes of cancer mortality.1 For decades, treatment […]
Yamey and Shaffer rightly warn that, when senior physicians appear beside President Trump and secretary of health and […]
Deal covers up to five candidates including SB36 as company expands global pipeline
